Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

AMETEK (AME) Financials

AMETEK logo
$186.80 +0.25 (+0.13%)
Closing price 03:59 PM Eastern
Extended Trading
$186.73 -0.07 (-0.04%)
As of 06:06 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for AMETEK

Annual Income Statements for AMETEK

This table shows AMETEK's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 584 591 512 681 778 861 872 990 1,160 1,313 1,376
Consolidated Net Income / (Loss)		 584 591 512 681 778 861 872 990 1,160 1,313 1,376
Net Income / (Loss) Continuing Operations		 584 591 512 681 778 861 872 990 1,160 1,313 1,376
Total Pre-Tax Income 		805 806 693 797 988 1,070 1,082 1,223 1,429 1,606 1,662
Total Operating Income		 899 908 791 904 1,076 1,177 1,028 1,309 1,501 1,707 1,780
Total Gross Profit		 1,361 1,356 1,255 1,439 1,660 1,788 1,544 1,913 2,145 2,384 2,476
Total Revenue		 4,022 3,974 3,840 4,300 4,846 5,159 4,540 5,547 6,151 6,597 6,941
Operating Revenue		 4,022 3,974 3,840 4,300 4,846 5,159 4,540 5,547 6,151 6,597 6,941
Total Cost of Revenue		 2,661 2,618 2,585 2,861 3,186 3,371 2,997 3,634 4,005 4,212 4,465
Operating Cost of Revenue		 2,661 2,618 2,585 2,861 3,186 3,371 2,997 3,634 4,005 4,212 4,465
Total Operating Expenses		 463 449 464 535 584 610 516 604 645 677 697
Selling, General & Admin Expense		 463 449 464 535 584 610 516 604 645 677 697
Total Other Income / (Expense), net		 -94 -101 -98 -107 -88 -108 54 -86 -72 -101 -118
Interest Expense		 80 92 94 98 82 88 86 80 83 82 113
Other Income / (Expense), net		 -14 -9.54 -3.57 -8.86 -5.62 -19 140 -5.12 11 -19 -5.06
Income Tax Expense		 220 216 181 115 210 208 210 233 269 293 285
Basic Earnings per Share		 $2.39 $2.46 $2.20 $2.96 $3.37 $3.78 $3.80 $4.29 $5.04 $5.70 $5.95
Weighted Average Basic Shares Outstanding		 244.89M 239.91M 232.59M 230.23M 230.82M 227.76M 229.44M 230.96M 230.21M 230.52M 231.26M
Diluted Earnings per Share		 $2.37 $2.45 $2.19 $2.94 $3.34 $3.75 $3.77 $4.25 $5.01 $5.67 $5.93
Weighted Average Diluted Shares Outstanding		 247.10M 241.59M 233.73M 231.85M 232.71M 229.40M 231.15M 232.81M 231.54M 231.51M 232.17M
Weighted Average Basic & Diluted Shares Outstanding		 244.50M 240.20M 232.80M 230.20M 230.80M 229.12M 230.56M 231.70M 230.09M 231.01M 230.66M

Quarterly Income Statements for AMETEK

This table shows AMETEK's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Net Income / (Loss) Attributable to Common Shareholders		 307 306 324 340 343 311 338 340 387 352 358
Consolidated Net Income / (Loss)		 307 306 324 340 343 311 338 340 387 352 358
Net Income / (Loss) Continuing Operations		 307 306 324 340 343 311 338 340 387 352 358
Total Pre-Tax Income 		379 380 396 413 417 381 417 419 444 434 442
Total Operating Income		 398 406 419 438 445 417 448 446 469 455 462
Total Gross Profit		 562 575 593 602 615 591 624 616 645 625 636
Total Revenue		 1,626 1,597 1,646 1,623 1,731 1,736 1,735 1,709 1,762 1,732 1,778
Operating Revenue		 1,626 1,597 1,646 1,623 1,731 1,736 1,735 1,709 1,762 1,732 1,778
Total Cost of Revenue		 1,064 1,023 1,053 1,021 1,116 1,145 1,110 1,093 1,117 1,107 1,142
Operating Cost of Revenue		 1,064 1,023 1,053 1,021 1,116 1,145 1,110 1,093 1,117 1,107 1,142
Total Operating Expenses		 164 169 174 164 170 174 177 170 176 170 174
Selling, General & Admin Expense		 164 169 174 164 170 174 177 170 176 170 174
Total Other Income / (Expense), net		 -20 -26 -22 -25 -28 -36 -31 -27 -25 -21 -19
Interest Expense		 23 21 19 18 24 35 31 25 22 19 17
Other Income / (Expense), net		 3.43 -5.37 -3.68 -6.26 -3.94 -0.63 0.09 -1.89 -2.63 -1.61 -2.60
Income Tax Expense		 71 74 72 73 74 70 79 79 57 82 84
Basic Earnings per Share		 $1.33 $1.33 $1.41 $1.48 $1.48 $1.35 $1.46 $1.47 $1.67 $1.52 $1.55
Weighted Average Basic Shares Outstanding		 230.21M 230.13M 230.48M 230.69M 230.52M 231.10M 231.44M 231.34M 231.26M 230.67M 230.82M
Diluted Earnings per Share		 $1.33 $1.32 $1.40 $1.47 $1.48 $1.34 $1.45 $1.47 $1.67 $1.52 $1.55
Weighted Average Diluted Shares Outstanding		 231.54M 231.23M 231.26M 231.75M 231.51M 232.04M 232.30M 232.22M 232.17M 231.54M 231.47M
Weighted Average Basic & Diluted Shares Outstanding		 230.09M 230.48M 230.71M 230.80M 231.01M 231.47M 231.54M 231.31M 230.66M 230.88M 230.95M
Cash Dividends to Common per Share		 - $0.25 $0.25 $0.25 - $0.28 $0.28 $0.28 - $0.31 $0.31

Annual Cash Flow Statements for AMETEK

This table details how cash moves in and out of AMETEK's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 82 3.39 336 -71 -292 39 820 -866 -1.39 64 -36
Net Cash From Operating Activities		 726 673 757 833 926 1,114 1,281 1,160 1,149 1,735 1,829
Net Cash From Continuing Operating Activities		 726 673 757 833 926 1,114 1,281 1,160 1,149 1,735 1,829
Net Income / (Loss) Continuing Operations		 584 591 512 681 778 861 872 990 1,160 1,313 1,376
Consolidated Net Income / (Loss)		 584 591 512 681 778 861 872 990 1,160 1,313 1,376
Depreciation Expense		 139 149 180 183 199 234 255 292 319 338 383
Non-Cash Adjustments To Reconcile Net Income		 21 20 26 18 20 50 -107 44 14 42 25
Changes in Operating Assets and Liabilities, net		 -19 -88 39 -49 -72 -31 261 -165 -343 42 45
Net Cash From Investing Activities		 -642 -426 -452 -626 -1,210 -1,151 62 -2,056 -553 -2,376 -245
Net Cash From Continuing Investing Activities		 -642 -426 -452 -626 -1,210 -1,151 62 -2,056 -553 -2,376 -245
Purchase of Property, Plant & Equipment		 -71 -69 -63 -75 -82 -102 -74 -111 -139 -136 -127
Acquisitions		 -574 -356 -391 -557 -1,129 -1,062 -117 -1,959 -430 -2,238 -118
Divestitures		 - - - - 0.00 0.00 245 12 3.73 0.00 0.00
Other Investing Activities, net		 2.39 -0.01 2.33 5.89 1.34 13 7.03 2.05 12 -2.27 -0.22
Net Cash From Financing Activities		 24 -217 57 -329 13 73 -539 39 -576 697 -1,602
Net Cash From Continuing Financing Activities		 24 -217 57 -329 13 73 -539 39 -576 697 -1,602
Repayment of Debt		 -173 45 -367 -280 -313 25 -435 -65 -17 -7.75 -309
Repurchase of Common Equity		 -245 -435 -336 -6.87 -368 -12 -4.69 -15 -333 -7.77 -212
Payment of Dividends		 -81 -86 -83 -83 -129 -127 -165 -185 -202 -230 -259
Issuance of Debt		 500 200 821 - 818 100 - 244 -74 892 -890
Other Financing Activities, net		 23 60 23 40 4.52 87 65 60 50 51 67
Other Net Changes in Cash		 - - - - - - - -10 -22 8.27 -17

Quarterly Cash Flow Statements for AMETEK

This table details how cash moves in and out of AMETEK's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Net Change in Cash & Equivalents		 35 54 206 236 -432 -36 23 -0.31 -22 25 221
Net Cash From Operating Activities		 385 387 335 473 541 410 381 487 550 418 359
Net Cash From Continuing Operating Activities		 385 387 335 473 541 410 381 487 550 418 359
Net Income / (Loss) Continuing Operations		 307 306 324 340 343 311 338 340 387 352 358
Consolidated Net Income / (Loss)		 307 306 324 340 343 311 338 340 387 352 358
Depreciation Expense		 88 82 82 82 92 98 99 90 96 106 108
Non-Cash Adjustments To Reconcile Net Income		 -4.72 13 7.98 2.24 19 4.90 7.47 3.28 9.12 4.41 11
Changes in Operating Assets and Liabilities, net		 -5.81 -14 -79 48 86 -3.62 -62 53 58 -45 -118
Net Cash From Investing Activities		 -297 -122 -28 -176 -2,050 -21 -22 -26 -175 -126 -30
Net Cash From Continuing Investing Activities		 -297 -122 -28 -176 -2,050 -21 -22 -26 -175 -126 -30
Purchase of Property, Plant & Equipment		 -58 -20 -28 -29 -60 -28 -21 -26 -52 -23 -29
Acquisitions		 -239 -99 - -147 -1,991 0.00 - - -118 -103 -0.95
Other Investing Activities, net		 0.35 -2.89 0.00 -0.26 0.88 6.24 -1.38 0.96 -6.05 0.52 0.20
Net Cash From Financing Activities		 -75 -215 -102 -48 1,062 -418 -334 -477 -374 -278 -132
Net Cash From Continuing Financing Activities		 -75 -215 -102 -48 1,062 -418 -334 -477 -374 -278 -132
Repayment of Debt		 -1.90 -5.89 0.95 -0.13 -2.68 -6.53 -2.03 -299 -0.80 -7.80 -50
Repurchase of Common Equity		 -1.40 -6.50 -0.02 -0.05 -1.19 -6.92 -0.68 -60 -144 -18 -0.11
Payment of Dividends		 -51 -57 -58 -58 -58 -65 -65 -65 -65 -71 -72
Issuance of Debt		 -47 -156 -64 -0.95 1,113 -363 -278 -57 -192 -185 -18
Other Financing Activities, net		 27 10 19 11 11 24 11 5.20 27 4.67 7.67
Other Net Changes in Cash		 22 5.08 0.42 -13 15 -7.31 -2.39 15 -23 11 23

Annual Balance Sheets for AMETEK

This table presents AMETEK's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets		 6,421 6,660 7,101 7,796 8,662 9,845 10,357 11,898 12,431 15,024 14,631
Total Current Assets		 1,579 1,619 1,928 1,935 1,836 2,026 2,522 2,129 2,528 2,825 2,603
Cash & Equivalents		 378 381 717 646 354 393 1,213 347 345 410 374
Accounts Receivable		 585 603 592 668 733 745 597 829 919 1,013 949
Inventories, net		 496 514 492 541 625 625 559 769 1,044 1,132 1,022
Other Current Assets		 75 73 76 80 125 263 153 184 219 269 258
Plant, Property, & Equipment, net		 448 485 473 493 554 549 527 617 636 891 819
Total Noncurrent Assets		 4,394 4,557 4,699 5,368 6,272 7,270 7,308 9,152 9,267 11,308 11,210
Long-Term Investments		 154 177 146 239 256 280 293 375 382 465 503
Goodwill		 2,614 2,707 2,819 3,116 3,612 4,048 4,225 5,239 5,373 6,448 6,556
Intangible Assets		 1,626 1,673 1,734 2,013 2,404 2,763 2,624 3,369 3,342 4,165 3,915
Other Noncurrent Operating Assets		 - - - - - 180 167 170 170 230 236
Total Liabilities & Shareholders' Equity		 6,421 6,660 7,101 7,796 8,662 9,845 10,357 11,898 12,431 15,024 14,631
Total Liabilities		 3,181 3,406 3,844 3,768 4,420 4,729 4,408 5,026 4,955 6,293 4,976
Total Current Liabilities		 936 1,024 924 1,139 1,259 1,426 1,076 1,563 1,564 2,883 2,099
Short-Term Debt		 286 385 279 308 359 497 132 315 226 1,418 654
Accounts Payable		 386 365 370 437 400 377 360 470 497 517 523
Accrued Expenses		 237 241 246 359 314 364 350 443 435 503 473
Current Deferred Revenue		 - - - 0.00 137 157 195 299 358 376 364
Current Deferred & Payable Income Tax Liabilities		 27 33 30 35 49 30 39 36 48 70 84
Total Noncurrent Liabilities		 2,245 2,382 2,920 2,630 3,162 3,303 3,332 3,463 3,390 3,411 2,877
Long-Term Debt		 1,428 1,553 2,063 1,866 2,274 2,271 2,281 2,229 2,159 1,895 1,425
Noncurrent Deferred & Payable Income Tax Liabilities		 618 624 622 513 528 536 533 720 694 837 831
Other Noncurrent Operating Liabilities		 199 205 235 251 359 496 517 514 537 679 621
Total Equity & Noncontrolling Interests		 3,240 3,255 3,257 4,028 4,242 5,115 5,949 6,872 7,477 8,730 9,655
Total Preferred & Common Equity		 3,240 3,255 3,257 4,028 4,242 5,115 5,949 6,872 7,477 8,730 9,655
Total Common Equity		 3,240 3,255 3,257 4,028 4,242 5,115 5,949 6,872 7,477 8,730 9,655
Common Stock		 494 571 607 664 709 835 924 1,015 1,097 1,171 1,267
Retained Earnings		 3,470 3,975 4,404 5,002 5,654 6,388 7,095 7,900 8,857 9,940 11,058
Treasury Stock		 -458 -885 -1,212 -1,209 -1,570 -1,574 -1,565 -1,573 -1,903 -1,897 -2,114
Accumulated Other Comprehensive Income / (Loss)		 -267 -406 -542 -429 -551 -533 -504 -470 -575 -485 -556

Quarterly Balance Sheets for AMETEK

This table presents AMETEK's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Total Assets		 12,431 12,616 12,840 13,093 15,024 14,865 14,796 14,768 14,631 14,877 15,267
Total Current Assets		 2,528 2,666 2,900 3,119 2,825 2,776 2,767 2,734 2,603 2,761 3,052
Cash & Equivalents		 345 400 606 842 410 374 397 396 374 399 620
Accounts Receivable		 919 902 937 937 1,013 984 976 968 949 997 1,021
Inventories, net		 1,044 1,117 1,108 1,088 1,132 1,127 1,102 1,085 1,022 1,070 1,111
Other Current Assets		 219 248 249 252 269 291 293 285 258 296 301
Plant, Property, & Equipment, net		 636 638 638 632 891 877 862 823 819 831 836
Total Noncurrent Assets		 9,267 9,312 9,303 9,343 11,308 11,212 11,167 11,211 11,210 11,285 11,378
Long-Term Investments		 382 394 402 415 465 473 483 499 503 509 528
Goodwill		 5,373 5,430 5,450 5,479 6,448 6,439 6,454 6,550 6,556 6,631 6,724
Intangible Assets		 3,342 3,321 3,279 3,284 4,165 4,081 4,013 3,951 3,915 3,917 3,880
Other Noncurrent Operating Assets		 170 167 172 165 230 220 217 211 236 228 246
Total Liabilities & Shareholders' Equity		 12,431 12,616 12,840 13,093 15,024 14,865 14,796 14,768 14,631 14,877 15,267
Total Liabilities		 4,955 4,859 4,758 4,751 6,293 5,897 5,543 5,217 4,976 4,907 4,878
Total Current Liabilities		 1,564 1,453 1,341 1,674 2,883 2,503 2,203 1,967 2,099 1,963 1,868
Short-Term Debt		 226 70 5.40 304 1,418 1,055 828 571 654 472 408
Accounts Payable		 497 526 488 487 517 517 510 512 523 534 549
Accrued Expenses		 435 372 417 458 503 452 440 469 473 447 454
Current Deferred Revenue		 358 378 383 363 376 392 378 351 364 387 380
Current Deferred & Payable Income Tax Liabilities		 48 107 48 62 70 86 47 65 84 123 78
Total Noncurrent Liabilities		 3,390 3,406 3,417 3,077 3,411 3,394 3,340 3,250 2,877 2,945 3,009
Long-Term Debt		 2,159 2,176 2,186 1,856 1,895 1,878 1,823 1,765 1,425 1,459 1,534
Noncurrent Deferred & Payable Income Tax Liabilities		 694 670 653 630 837 837 819 793 831 845 808
Other Noncurrent Operating Liabilities		 537 560 578 591 679 680 698 692 621 641 667
Total Equity & Noncontrolling Interests		 7,477 7,757 8,081 8,343 8,730 8,968 9,252 9,550 9,655 9,970 10,389
Total Preferred & Common Equity		 7,477 7,757 8,081 8,343 8,730 8,968 9,252 9,550 9,655 9,970 10,389
Total Common Equity		 7,477 7,757 8,081 8,343 8,730 8,968 9,252 9,550 9,655 9,970 10,389
Common Stock		 1,097 1,095 1,127 1,151 1,171 1,189 1,213 1,231 1,267 1,258 1,279
Retained Earnings		 8,857 9,106 9,372 9,655 9,940 10,187 10,460 10,735 11,058 11,338 11,625
Treasury Stock		 -1,903 -1,895 -1,896 -1,896 -1,897 -1,897 -1,898 -1,959 -2,114 -2,108 -2,108
Accumulated Other Comprehensive Income / (Loss)		 -575 -548 -522 -568 -485 -510 -522 -458 -556 -518 -406

Annual Metrics And Ratios for AMETEK

This table displays calculated financial ratios and metrics derived from AMETEK's official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 11.90% -1.19% -3.38% 11.98% 12.69% 6.45% -11.99% 22.17% 10.89% 7.26% 5.22%
EBITDA Growth		 11.59% 2.37% -7.69% 11.46% 17.76% 9.68% 2.25% 12.08% 14.77% 10.62% 6.50%
EBIT Growth		 10.82% 1.52% -12.33% 13.63% 19.58% 8.25% 0.88% 11.57% 15.98% 11.66% 5.11%
NOPAT Growth		 12.24% 1.93% -12.12% 32.24% 9.60% 11.91% -12.59% 27.84% 14.98% 14.60% 5.59%
Net Income Growth		 13.05% 1.09% -13.32% 33.06% 14.16% 10.72% 1.29% 13.48% 17.12% 13.25% 4.79%
EPS Growth		 12.86% 3.38% -10.61% 34.25% 13.61% 12.28% 0.53% 12.73% 17.88% 13.17% 4.59%
Operating Cash Flow Growth		 9.88% -7.36% 12.53% 10.10% 11.07% 20.41% 14.95% -9.41% -0.96% 50.98% 5.39%
Free Cash Flow Firm Growth		 2.73% 71.96% 6.97% -60.56% -152.83% 100.98% 118,988.55% -165.76% 200.16% -182.11% 379.09%
Invested Capital Growth		 9.66% 4.81% 2.17% 12.29% 17.83% 15.12% -4.91% 26.78% 5.05% 22.28% -2.78%
Revenue Q/Q Growth		 2.07% -0.90% -0.39% 4.12% 2.72% 0.65% -2.28% 5.81% 2.02% 1.62% 0.44%
EBITDA Q/Q Growth		 2.90% -1.95% -1.97% 4.70% 4.85% 1.64% 0.42% 5.03% 2.95% 2.17% 1.37%
EBIT Q/Q Growth		 2.88% -2.66% -4.46% 6.29% 5.66% 1.04% 0.44% 5.13% 2.84% 2.40% 1.45%
NOPAT Q/Q Growth		 2.06% -1.50% -5.55% 24.18% -4.42% 1.56% -0.73% 6.19% 1.94% 3.18% 3.02%
Net Income Q/Q Growth		 2.87% -2.50% -5.14% 23.44% -3.36% 1.09% 0.03% 6.53% 2.24% 2.80% 3.33%
EPS Q/Q Growth		 2.60% -2.00% -4.37% 23.53% -3.47% 1.35% -0.26% 6.52% 2.45% 2.72% 3.31%
Operating Cash Flow Q/Q Growth		 -33.00% -2.03% 6.76% 0.67% 4.91% 4.31% 3.53% -8.22% 9.86% 9.85% 0.51%
Free Cash Flow Firm Q/Q Growth		 2,588.48% 7.05% 3.45% -16.39% -118.35% -99.63% 441.43% -26.83% -17.97% -172.61% 667.35%
Invested Capital Q/Q Growth		 -1.82% -2.57% -3.52% 0.29% 11.12% 14.43% -0.88% 1.94% 4.10% 20.79% -1.22%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 33.84% 34.13% 32.67% 33.46% 34.25% 34.65% 34.00% 34.48% 34.88% 36.15% 35.68%
EBITDA Margin		 25.44% 26.36% 25.18% 25.07% 26.20% 26.99% 31.36% 28.77% 29.77% 30.71% 31.08%
Operating Margin		 22.34% 22.84% 20.60% 21.01% 22.20% 22.82% 22.64% 23.59% 24.40% 25.88% 25.64%
EBIT Margin		 22.00% 22.60% 20.50% 20.81% 22.08% 22.45% 25.73% 23.50% 24.58% 25.59% 25.56%
Profit (Net Income) Margin		 14.53% 14.87% 13.34% 15.85% 16.05% 16.70% 19.22% 17.85% 18.85% 19.91% 19.83%
Tax Burden Percent		 72.62% 73.27% 73.89% 85.53% 78.76% 80.51% 80.61% 80.94% 81.16% 81.75% 82.82%
Interest Burden Percent		 90.97% 89.78% 88.02% 89.04% 92.32% 92.36% 92.63% 93.83% 94.50% 95.15% 93.63%
Effective Tax Rate		 27.38% 26.73% 26.11% 14.47% 21.24% 19.49% 19.39% 19.06% 18.84% 18.25% 17.18%
Return on Invested Capital (ROIC)		 15.44% 14.69% 12.48% 15.38% 14.63% 14.07% 11.78% 13.62% 13.66% 13.75% 13.38%
ROIC Less NNEP Spread (ROIC-NNEP)		 8.89% 8.89% 7.42% 8.77% 10.45% 9.86% 14.70% 8.55% 10.30% 9.72% 8.01%
Return on Net Nonoperating Assets (RNNOA)		 2.90% 3.51% 3.25% 3.33% 4.19% 4.34% 3.99% 1.82% 2.50% 2.46% 1.59%
Return on Equity (ROE)		 18.33% 18.20% 15.73% 18.71% 18.81% 18.41% 15.77% 15.44% 16.16% 16.21% 14.97%
Cash Return on Invested Capital (CROIC)		 6.23% 10.00% 10.33% 3.80% -1.74% 0.01% 16.81% -10.00% 8.74% -6.30% 16.20%
Operating Return on Assets (OROA)		 14.39% 13.73% 11.44% 12.01% 13.00% 12.52% 11.57% 11.71% 12.43% 12.30% 11.97%
Return on Assets (ROA)		 9.50% 9.03% 7.44% 9.15% 9.45% 9.31% 8.64% 8.90% 9.53% 9.57% 9.28%
Return on Common Equity (ROCE)		 18.33% 18.20% 15.73% 18.71% 18.81% 18.41% 15.77% 15.44% 16.16% 16.21% 14.97%
Return on Equity Simple (ROE_SIMPLE)		 18.04% 18.15% 15.73% 16.92% 18.34% 16.84% 14.66% 14.41% 15.51% 15.04% 14.25%
Net Operating Profit after Tax (NOPAT)		 653 665 584 773 847 948 829 1,059 1,218 1,396 1,474
NOPAT Margin		 16.22% 16.74% 15.22% 17.97% 17.48% 18.38% 18.25% 19.10% 19.80% 21.16% 21.23%
Net Nonoperating Expense Percent (NNEP)		 6.55% 5.80% 5.06% 6.61% 4.18% 4.21% -2.92% 5.07% 3.36% 4.03% 5.37%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - 12.35% 11.59% 12.56%
Cost of Revenue to Revenue		 66.16% 65.87% 67.33% 66.54% 65.75% 65.35% 66.00% 65.52% 65.12% 63.86% 64.32%
SG&A Expenses to Revenue		 11.50% 11.29% 12.07% 12.45% 12.05% 11.83% 11.36% 10.89% 10.48% 10.26% 10.04%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 11.50% 11.29% 12.07% 12.45% 12.05% 11.83% 11.36% 10.89% 10.48% 10.26% 10.04%
Earnings before Interest and Taxes (EBIT)		 885 898 787 895 1,070 1,158 1,168 1,304 1,512 1,688 1,775
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 1,023 1,048 967 1,078 1,269 1,392 1,424 1,596 1,831 2,026 2,157
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 3.75 3.70 3.29 3.98 3.57 4.32 4.57 4.87 4.24 4.33 4.32
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 3.02 3.03 2.79 3.73 3.13 4.29 5.99 6.03 5.15 5.73 6.01
Price to Earnings (P/E)		 20.77 20.37 20.89 23.52 19.47 25.68 31.18 33.79 27.32 28.80 30.30
Dividend Yield		 0.67% 0.71% 0.78% 0.52% 0.86% 0.58% 0.61% 0.55% 0.64% 0.61% 0.62%
Earnings Yield		 4.81% 4.91% 4.79% 4.25% 5.14% 3.89% 3.21% 2.96% 3.66% 3.47% 3.30%
Enterprise Value to Invested Capital (EV/IC)		 3.01 2.90 2.57 3.26 2.74 3.36 4.10 4.06 3.65 3.60 3.95
Enterprise Value to Revenue (EV/Rev)		 3.31 3.38 3.17 4.03 3.54 4.69 6.19 6.36 5.42 6.10 6.18
Enterprise Value to EBITDA (EV/EBITDA)		 13.02 12.81 12.59 16.06 13.53 17.39 19.74 22.11 18.20 19.87 19.88
Enterprise Value to EBIT (EV/EBIT)		 15.06 14.94 15.47 19.35 16.05 20.91 24.06 27.06 22.05 23.85 24.17
Enterprise Value to NOPAT (EV/NOPAT)		 20.42 20.17 20.84 22.40 20.27 25.54 33.92 33.30 27.37 28.84 29.11
Enterprise Value to Operating Cash Flow (EV/OCF)		 18.35 19.95 16.09 20.78 18.55 21.73 21.94 30.40 29.00 23.20 23.46
Enterprise Value to Free Cash Flow (EV/FCFF)		 50.62 29.64 25.15 90.68 0.00 24,387.54 23.77 0.00 42.80 0.00 24.04
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.53 0.60 0.72 0.54 0.62 0.54 0.41 0.37 0.32 0.38 0.22
Long-Term Debt to Equity		 0.44 0.48 0.63 0.46 0.54 0.44 0.38 0.32 0.29 0.22 0.15
Financial Leverage		 0.33 0.39 0.44 0.38 0.40 0.44 0.27 0.21 0.24 0.25 0.20
Leverage Ratio		 1.93 2.01 2.11 2.05 1.99 1.98 1.83 1.74 1.70 1.69 1.61
Compound Leverage Factor		 1.75 1.81 1.86 1.82 1.84 1.83 1.69 1.63 1.60 1.61 1.51
Debt to Total Capital		 34.60% 37.32% 41.83% 35.06% 38.30% 35.12% 28.86% 27.02% 24.19% 27.51% 17.72%
Short-Term Debt to Total Capital		 5.78% 7.41% 4.98% 4.97% 5.22% 6.31% 1.58% 3.35% 2.29% 11.77% 5.58%
Long-Term Debt to Total Capital		 28.82% 29.91% 36.85% 30.09% 33.08% 28.81% 27.28% 23.67% 21.89% 15.74% 12.15%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 65.40% 62.68% 58.17% 64.94% 61.70% 64.88% 71.14% 72.98% 75.82% 72.49% 82.28%
Debt to EBITDA		 1.67 1.85 2.42 2.02 2.07 1.99 1.70 1.59 1.30 1.64 0.96
Net Debt to EBITDA		 1.16 1.32 1.53 1.20 1.59 1.51 0.64 1.14 0.90 1.20 0.56
Long-Term Debt to EBITDA		 1.40 1.48 2.13 1.73 1.79 1.63 1.60 1.40 1.18 0.94 0.66
Debt to NOPAT		 2.63 2.91 4.01 2.81 3.11 2.92 2.91 2.40 1.96 2.37 1.41
Net Debt to NOPAT		 1.81 2.07 2.53 1.67 2.39 2.21 1.10 1.72 1.36 1.75 0.82
Long-Term Debt to NOPAT		 2.19 2.34 3.53 2.41 2.68 2.40 2.75 2.10 1.77 1.36 0.97
Altman Z-Score		 4.25 4.10 3.61 4.50 4.02 4.70 5.64 5.81 5.82 5.34 7.00
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.69 1.58 2.09 1.70 1.46 1.42 2.34 1.36 1.62 0.98 1.24
Quick Ratio		 1.03 0.96 1.42 1.15 0.86 0.80 1.68 0.75 0.81 0.49 0.63
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 263 453 484 191 -101 0.99 1,182 -777 779 -639 1,784
Operating Cash Flow to CapEx		 1,031.53% 973.52% 1,196.01% 1,109.92% 1,127.64% 1,088.88% 1,726.41% 1,048.56% 826.86% 1,273.62% 1,439.19%
Free Cash Flow to Firm to Interest Expense		 3.29 4.93 5.13 1.95 -1.23 0.01 13.74 -9.67 9.36 -7.82 15.80
Operating Cash Flow to Interest Expense		 9.08 7.33 8.03 8.50 11.26 12.60 14.88 14.44 13.82 21.22 16.19
Operating Cash Flow Less CapEx to Interest Expense		 8.20 6.57 7.35 7.73 10.26 11.44 14.02 13.06 12.15 19.55 15.07
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.65 0.61 0.56 0.58 0.59 0.56 0.45 0.50 0.51 0.48 0.47
Accounts Receivable Turnover		 7.17 6.69 6.42 6.82 6.92 6.98 6.76 7.78 7.04 6.83 7.08
Inventory Turnover		 5.61 5.18 5.14 5.54 5.47 5.40 5.06 5.47 4.42 3.87 4.15
Fixed Asset Turnover		 9.45 8.52 8.02 8.90 9.25 9.35 8.44 9.70 9.82 8.64 8.12
Accounts Payable Turnover		 7.25 6.97 7.04 7.09 7.61 8.68 8.13 8.75 8.28 8.31 8.59
Days Sales Outstanding (DSO)		 50.92 54.59 56.82 53.50 52.76 52.27 53.96 46.94 51.88 53.45 51.58
Days Inventory Outstanding (DIO)		 65.07 70.43 71.05 65.86 66.74 67.64 72.09 66.71 82.63 94.30 88.05
Days Payable Outstanding (DPO)		 50.33 52.39 51.87 51.46 47.93 42.06 44.92 41.72 44.08 43.92 42.51
Cash Conversion Cycle (CCC)		 65.66 72.63 76.00 67.89 71.57 77.86 81.13 71.94 90.43 103.84 97.13
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 4,422 4,634 4,735 5,316 6,264 7,211 6,858 8,694 9,134 11,169 10,858
Invested Capital Turnover		 0.95 0.88 0.82 0.86 0.84 0.77 0.65 0.71 0.69 0.65 0.63
Increase / (Decrease) in Invested Capital		 389 213 100 582 948 947 -354 1,837 439 2,035 -311
Enterprise Value (EV)		 13,322 13,416 12,178 17,315 17,169 24,213 28,107 35,275 33,331 40,257 42,898
Market Capitalization		 12,140 12,037 10,700 16,026 15,147 22,117 27,199 33,452 31,674 37,818 41,696
Book Value per Share		 $13.17 $13.68 $14.07 $17.43 $18.28 $22.38 $25.86 $29.71 $32.56 $37.83 $41.74
Tangible Book Value per Share		 ($4.07) ($4.73) ($5.60) ($4.77) ($7.64) ($7.41) ($3.91) ($7.50) ($5.39) ($8.16) ($3.53)
Total Capital		 4,954 5,193 5,598 6,202 6,875 7,884 8,363 9,416 9,862 12,044 11,735
Total Debt		 1,714 1,938 2,342 2,174 2,633 2,769 2,414 2,544 2,385 3,313 2,080
Total Long-Term Debt		 1,428 1,553 2,063 1,866 2,274 2,271 2,281 2,229 2,159 1,895 1,425
Net Debt		 1,182 1,380 1,478 1,289 2,023 2,096 908 1,822 1,657 2,439 1,203
Capital Expenditures (CapEx)		 70 69 63 75 82 102 74 111 139 136 127
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 551 599 565 458 582 704 366 534 845 950 785
Debt-free Net Working Capital (DFNWC)		 929 980 1,283 1,104 936 1,097 1,579 881 1,190 1,360 1,159
Net Working Capital (NWC)		 642 595 1,004 796 577 600 1,447 565 964 -58 504
Net Nonoperating Expense (NNE)		 68 74 72 91 69 87 -44 69 58 83 98
Net Nonoperating Obligations (NNO)		 1,182 1,380 1,478 1,289 2,023 2,096 908 1,822 1,657 2,439 1,203
Total Depreciation and Amortization (D&A)		 139 149 180 183 199 234 255 292 319 338 383
Debt-free, Cash-free Net Working Capital to Revenue		 13.70% 15.06% 14.72% 10.65% 12.02% 13.65% 8.06% 9.62% 13.73% 14.40% 11.31%
Debt-free Net Working Capital to Revenue		 23.09% 24.65% 33.40% 25.68% 19.32% 21.27% 34.78% 15.88% 19.35% 20.62% 16.69%
Net Working Capital to Revenue		 15.97% 14.97% 26.14% 18.51% 11.92% 11.63% 31.86% 10.19% 15.67% -0.88% 7.27%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $2.39 $2.46 $2.20 $2.96 $3.37 $3.78 $3.80 $4.29 $5.04 $5.70 $5.95
Adjusted Weighted Average Basic Shares Outstanding		 244.89M 239.91M 232.59M 230.23M 230.82M 227.76M 229.44M 230.96M 230.21M 230.52M 231.26M
Adjusted Diluted Earnings per Share		 $2.37 $2.45 $2.19 $2.94 $3.34 $3.75 $3.77 $4.25 $5.01 $5.67 $5.93
Adjusted Weighted Average Diluted Shares Outstanding		 247.10M 241.59M 233.73M 231.85M 232.71M 229.40M 231.15M 232.81M 231.54M 231.51M 232.17M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 241.07M 235.54M 229.47M 231.33M 227.13M 229.12M 230.56M 231.70M 230.09M 231.01M 230.66M
Normalized Net Operating Profit after Tax (NOPAT)		 653 665 584 773 847 948 829 1,059 1,218 1,396 1,474
Normalized NOPAT Margin		 16.22% 16.74% 15.22% 17.97% 17.48% 18.38% 18.25% 19.10% 19.80% 21.16% 21.23%
Pre Tax Income Margin		 20.01% 20.29% 18.05% 18.53% 20.38% 20.74% 23.84% 22.05% 23.23% 24.35% 23.94%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 11.07 9.78 8.35 9.13 13.02 13.09 13.58 16.22 18.17 20.64 15.71
NOPAT to Interest Expense		 8.16 7.25 6.20 7.88 10.31 10.71 9.63 13.18 14.64 17.06 13.05
EBIT Less CapEx to Interest Expense		 10.19 9.03 7.68 8.36 12.02 11.93 12.71 14.84 16.50 18.97 14.58
NOPAT Less CapEx to Interest Expense		 7.28 6.49 5.53 7.12 9.31 9.56 8.77 11.80 12.97 15.40 11.92
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 13.78% 14.55% 16.26% 12.14% 16.57% 14.80% 18.92% 18.65% 17.44% 17.54% 18.81%
Augmented Payout Ratio		 55.75% 88.24% 81.89% 13.15% 63.83% 16.19% 19.45% 20.13% 46.14% 18.13% 34.21%

Quarterly Metrics And Ratios for AMETEK

This table displays calculated financial ratios and metrics derived from AMETEK's official financial filings.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 8.11% 9.50% 8.69% 4.58% 6.47% 8.71% 5.39% 5.28% 1.77% -0.24% 2.49%
EBITDA Growth		 12.02% 11.21% 11.88% 10.82% 8.77% 6.64% 9.99% 4.02% 5.49% 8.74% 3.74%
EBIT Growth		 11.59% 12.47% 13.17% 11.38% 9.84% 4.10% 7.83% 2.80% 5.74% 8.79% 2.55%
NOPAT Growth		 7.72% 14.10% 15.21% 15.81% 13.30% 4.16% 5.78% 0.42% 11.69% 8.30% 3.24%
Net Income Growth		 9.02% 12.21% 14.83% 14.36% 11.65% 1.71% 4.15% -0.04% 12.95% 13.13% 6.13%
EPS Growth		 9.92% 12.82% 14.75% 13.95% 11.28% 1.52% 3.57% 0.00% 12.84% 13.43% 6.90%
Operating Cash Flow Growth		 36.58% 91.98% 42.12% 44.55% 40.42% 6.13% 13.78% 3.03% 1.73% 1.78% -5.86%
Free Cash Flow Firm Growth		 92.43% 89.80% -217.59% -269.20% -1,334.87% -952.89% -539.02% -1,139.77% 143.09% 128.60% 115.45%
Invested Capital Growth		 5.05% 5.37% 6.45% 5.38% 22.28% 20.04% 18.99% 18.87% -2.78% -0.56% 1.44%
Revenue Q/Q Growth		 4.76% -1.76% 3.07% -1.41% 6.66% 0.31% -0.08% -1.51% 3.10% -1.68% 2.66%
EBITDA Q/Q Growth		 5.71% -1.52% 2.93% 3.42% 3.76% -3.45% 6.16% -2.19% 5.22% -0.47% 1.28%
EBIT Q/Q Growth		 3.55% -0.34% 3.73% 4.04% 2.12% -5.55% 7.45% -0.81% 5.04% -2.82% 1.28%
NOPAT Q/Q Growth		 3.71% 1.12% 4.89% 5.28% 1.46% -7.03% 6.52% -0.06% 12.85% -9.85% 1.54%
Net Income Q/Q Growth		 3.17% -0.45% 6.06% 4.97% 0.73% -9.31% 8.60% 0.76% 13.82% -9.17% 1.88%
EPS Q/Q Growth		 3.10% -0.75% 6.06% 5.00% 0.68% -9.46% 8.21% 1.38% 13.61% -8.98% 1.97%
Operating Cash Flow Q/Q Growth		 17.70% 0.40% -13.27% 41.05% 14.34% -24.12% -7.02% 27.72% 12.90% -24.08% -14.00%
Free Cash Flow Firm Q/Q Growth		 -276.45% -22.89% -52.89% 48.96% -1,396.30% 9.83% 7.21% 0.97% 152.01% -40.15% -49.89%
Invested Capital Q/Q Growth		 4.10% 0.83% 0.61% -0.20% 20.79% -1.02% -0.28% -0.29% -1.22% 1.24% 1.73%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 34.57% 35.98% 36.02% 37.09% 35.53% 34.07% 35.99% 36.04% 36.60% 36.09% 35.76%
EBITDA Margin		 30.14% 30.21% 30.17% 31.65% 30.79% 29.64% 31.49% 31.27% 31.92% 32.31% 31.87%
Operating Margin		 24.49% 25.39% 25.44% 27.00% 25.71% 24.03% 25.80% 26.10% 26.62% 26.26% 25.96%
EBIT Margin		 24.70% 25.06% 25.22% 26.61% 25.48% 23.99% 25.80% 25.98% 26.47% 26.17% 25.82%
Profit (Net Income) Margin		 18.89% 19.14% 19.70% 20.97% 19.81% 17.91% 19.46% 19.91% 21.98% 20.31% 20.16%
Tax Burden Percent		 81.13% 80.54% 81.80% 82.32% 82.23% 81.54% 80.98% 81.23% 87.15% 81.01% 81.05%
Interest Burden Percent		 94.27% 94.86% 95.49% 95.74% 94.53% 91.54% 93.17% 94.34% 95.28% 95.81% 96.33%
Effective Tax Rate		 18.87% 19.46% 18.20% 17.68% 17.77% 18.46% 19.02% 18.77% 12.85% 18.99% 18.95%
Return on Invested Capital (ROIC)		 13.71% 14.33% 14.87% 16.01% 13.74% 13.03% 14.05% 14.48% 14.62% 13.39% 13.23%
ROIC Less NNEP Spread (ROIC-NNEP)		 12.79% 13.05% 13.62% 14.42% 12.61% 11.37% 12.38% 12.61% 13.44% 12.31% 12.00%
Return on Net Nonoperating Assets (RNNOA)		 3.10% 2.90% 2.66% 2.37% 3.19% 2.41% 2.11% 1.65% 2.66% 2.02% 1.57%
Return on Equity (ROE)		 16.81% 17.23% 17.53% 18.38% 16.93% 15.43% 16.16% 16.13% 17.29% 15.41% 14.80%
Cash Return on Invested Capital (CROIC)		 8.74% 8.79% 8.26% 9.77% -6.30% -4.30% -3.25% -3.11% 16.20% 14.19% 12.20%
Operating Return on Assets (OROA)		 12.49% 12.82% 13.04% 13.75% 12.25% 11.76% 12.74% 12.89% 12.39% 12.21% 11.99%
Return on Assets (ROA)		 9.55% 9.79% 10.19% 10.84% 9.52% 8.78% 9.61% 9.88% 10.29% 9.47% 9.36%
Return on Common Equity (ROCE)		 16.81% 17.23% 17.53% 18.38% 16.93% 15.43% 16.16% 16.13% 17.29% 15.41% 14.80%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 15.38% 15.28% 15.31% 0.00% 14.70% 14.39% 13.94% 0.00% 14.21% 0.00%
Net Operating Profit after Tax (NOPAT)		 323 327 343 361 366 340 362 362 409 368 374
NOPAT Margin		 19.87% 20.45% 20.81% 22.22% 21.14% 19.60% 20.89% 21.20% 23.20% 21.27% 21.04%
Net Nonoperating Expense Percent (NNEP)		 0.91% 1.28% 1.25% 1.59% 1.13% 1.65% 1.67% 1.87% 1.18% 1.07% 1.23%
Return On Investment Capital (ROIC_SIMPLE)		 3.28% - - - 3.04% - - - 3.48% 3.10% 3.03%
Cost of Revenue to Revenue		 65.43% 64.02% 63.98% 62.91% 64.47% 65.93% 64.01% 63.96% 63.40% 63.91% 64.24%
SG&A Expenses to Revenue		 10.08% 10.58% 10.58% 10.09% 9.82% 10.04% 10.20% 9.95% 9.98% 9.83% 9.80%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 10.08% 10.58% 10.58% 10.09% 9.82% 10.04% 10.20% 9.95% 9.98% 9.83% 9.80%
Earnings before Interest and Taxes (EBIT)		 402 400 415 432 441 417 448 444 466 453 459
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 490 483 497 514 533 515 546 534 562 560 567
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 4.24 4.28 4.59 4.06 4.33 4.70 4.17 4.16 4.32 3.98 4.02
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 5.15 5.27 5.77 5.22 5.73 6.26 5.65 5.75 6.01 5.72 5.99
Price to Earnings (P/E)		 27.32 27.81 30.02 26.52 28.80 31.97 28.97 29.85 30.30 28.02 29.06
Dividend Yield		 0.64% 0.63% 0.58% 0.66% 0.61% 0.56% 0.64% 0.63% 0.62% 0.67% 0.65%
Earnings Yield		 3.66% 3.60% 3.33% 3.77% 3.47% 3.13% 3.45% 3.35% 3.30% 3.57% 3.44%
Enterprise Value to Invested Capital (EV/IC)		 3.65 3.76 4.13 3.76 3.60 4.00 3.66 3.75 3.95 3.71 3.81
Enterprise Value to Revenue (EV/Rev)		 5.42 5.51 5.96 5.36 6.10 6.57 5.91 5.96 6.18 5.87 6.10
Enterprise Value to EBITDA (EV/EBITDA)		 18.20 18.42 19.79 17.54 19.87 21.49 19.15 19.36 19.88 18.49 19.15
Enterprise Value to EBIT (EV/EBIT)		 22.05 22.25 23.84 21.09 23.85 25.95 23.23 23.55 24.17 22.49 23.36
Enterprise Value to NOPAT (EV/NOPAT)		 27.37 27.51 29.35 25.71 28.84 31.38 28.24 28.80 29.11 27.12 28.13
Enterprise Value to Operating Cash Flow (EV/OCF)		 29.00 25.94 26.68 22.01 23.20 25.15 22.36 22.64 23.46 22.18 23.47
Enterprise Value to Free Cash Flow (EV/FCFF)		 42.80 43.89 51.52 39.49 0.00 0.00 0.00 0.00 24.04 26.04 31.42
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.32 0.29 0.27 0.26 0.38 0.33 0.29 0.24 0.22 0.19 0.19
Long-Term Debt to Equity		 0.29 0.28 0.27 0.22 0.22 0.21 0.20 0.18 0.15 0.15 0.15
Financial Leverage		 0.24 0.22 0.20 0.16 0.25 0.21 0.17 0.13 0.20 0.16 0.13
Leverage Ratio		 1.70 1.67 1.65 1.62 1.69 1.64 1.59 1.56 1.61 1.57 1.53
Compound Leverage Factor		 1.60 1.59 1.58 1.55 1.60 1.50 1.49 1.47 1.54 1.50 1.47
Debt to Total Capital		 24.19% 22.45% 21.33% 20.57% 27.51% 24.65% 22.27% 19.66% 17.72% 16.23% 15.75%
Short-Term Debt to Total Capital		 2.29% 0.70% 0.05% 2.90% 11.77% 8.87% 6.96% 4.80% 5.58% 3.96% 3.31%
Long-Term Debt to Total Capital		 21.89% 21.75% 21.28% 17.67% 15.74% 15.78% 15.32% 14.85% 12.15% 12.26% 12.44%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 75.82% 77.55% 78.67% 79.43% 72.49% 75.35% 77.73% 80.34% 82.28% 83.77% 84.25%
Debt to EBITDA		 1.30 1.19 1.13 1.09 1.64 1.43 1.26 1.10 0.96 0.88 0.87
Net Debt to EBITDA		 0.90 0.77 0.61 0.46 1.20 1.01 0.84 0.68 0.56 0.46 0.36
Long-Term Debt to EBITDA		 1.18 1.16 1.13 0.94 0.94 0.91 0.87 0.83 0.66 0.66 0.69
Debt to NOPAT		 1.96 1.78 1.68 1.60 2.37 2.08 1.86 1.63 1.41 1.29 1.28
Net Debt to NOPAT		 1.36 1.15 0.91 0.67 1.75 1.48 1.24 1.01 0.82 0.68 0.52
Long-Term Debt to NOPAT		 1.77 1.73 1.68 1.37 1.36 1.33 1.28 1.23 0.97 0.97 1.01
Altman Z-Score		 5.53 5.83 6.45 6.05 5.06 5.82 5.77 6.22 6.71 6.55 6.85
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.62 1.84 2.16 1.86 0.98 1.11 1.26 1.39 1.24 1.41 1.63
Quick Ratio		 0.81 0.90 1.15 1.06 0.49 0.54 0.62 0.69 0.63 0.71 0.88
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -116 -143 -219 -112 -1,669 -1,505 -1,397 -1,383 719 431 216
Operating Cash Flow to CapEx		 661.81% 1,932.10% 1,204.67% 1,649.25% 904.97% 1,483.53% 1,781.07% 1,853.63% 1,063.35% 1,809.98% 1,226.86%
Free Cash Flow to Firm to Interest Expense		 -5.05 -6.95 -11.67 -6.07 -69.21 -42.70 -45.66 -55.06 32.70 22.67 12.80
Operating Cash Flow to Interest Expense		 16.72 18.79 17.91 25.72 22.42 11.64 12.47 19.40 25.00 21.98 21.30
Operating Cash Flow Less CapEx to Interest Expense		 14.20 17.82 16.42 24.16 19.94 10.85 11.77 18.35 22.65 20.77 19.57
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.51 0.51 0.52 0.52 0.48 0.49 0.49 0.50 0.47 0.47 0.46
Accounts Receivable Turnover		 7.04 7.16 7.05 7.16 6.83 7.15 7.13 7.25 7.08 7.01 6.99
Inventory Turnover		 4.42 4.11 4.00 3.94 3.87 3.86 3.98 4.11 4.15 4.03 4.03
Fixed Asset Turnover		 9.82 10.07 10.40 10.58 8.64 8.89 9.11 9.50 8.12 8.12 8.22
Accounts Payable Turnover		 8.28 7.92 8.06 8.23 8.31 8.31 8.80 8.94 8.59 8.42 8.41
Days Sales Outstanding (DSO)		 51.88 50.96 51.79 50.98 53.45 51.08 51.16 50.31 51.58 52.10 52.22
Days Inventory Outstanding (DIO)		 82.63 88.75 91.36 92.68 94.30 94.49 91.82 88.81 88.05 90.56 90.55
Days Payable Outstanding (DPO)		 44.08 46.10 45.29 44.34 43.92 43.93 41.48 40.81 42.51 43.36 43.38
Cash Conversion Cycle (CCC)		 90.43 93.60 97.86 99.31 103.84 101.65 101.50 98.31 97.13 99.31 99.39
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 9,134 9,209 9,265 9,247 11,169 11,055 11,024 10,992 10,858 10,993 11,183
Invested Capital Turnover		 0.69 0.70 0.71 0.72 0.65 0.66 0.67 0.68 0.63 0.63 0.63
Increase / (Decrease) in Invested Capital		 439 470 561 472 2,035 1,845 1,759 1,745 -311 -62 158
Enterprise Value (EV)		 33,331 34,623 38,255 34,775 40,257 44,232 40,360 41,199 42,898 40,728 42,574
Market Capitalization		 31,674 33,171 37,071 33,871 37,818 42,145 38,588 39,757 41,696 39,706 41,780
Book Value per Share		 $32.56 $33.71 $35.06 $36.16 $37.83 $38.81 $39.97 $41.25 $41.74 $43.22 $45.00
Tangible Book Value per Share		 ($5.39) ($4.32) ($2.81) ($1.82) ($8.16) ($6.71) ($5.25) ($4.11) ($3.53) ($2.51) ($0.93)
Total Capital		 9,862 10,003 10,273 10,503 12,044 11,901 11,904 11,887 11,735 11,901 12,331
Total Debt		 2,385 2,246 2,192 2,161 3,313 2,933 2,651 2,337 2,080 1,931 1,942
Total Long-Term Debt		 2,159 2,176 2,186 1,856 1,895 1,878 1,823 1,765 1,425 1,459 1,534
Net Debt		 1,657 1,452 1,184 904 2,439 2,087 1,772 1,442 1,203 1,023 794
Capital Expenditures (CapEx)		 58 20 28 29 60 28 21 26 52 23 29
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 845 883 958 908 950 955 996 942 785 871 971
Debt-free Net Working Capital (DFNWC)		 1,190 1,283 1,564 1,749 1,360 1,328 1,392 1,338 1,159 1,270 1,591
Net Working Capital (NWC)		 964 1,213 1,558 1,445 -58 273 564 767 504 798 1,183
Net Nonoperating Expense (NNE)		 16 21 18 20 23 29 25 22 21 17 16
Net Nonoperating Obligations (NNO)		 1,657 1,452 1,184 904 2,439 2,087 1,772 1,442 1,203 1,023 794
Total Depreciation and Amortization (D&A)		 88 82 82 82 92 98 99 90 96 106 108
Debt-free, Cash-free Net Working Capital to Revenue		 13.73% 14.05% 14.92% 13.98% 14.40% 14.17% 14.59% 13.63% 11.31% 12.55% 13.92%
Debt-free Net Working Capital to Revenue		 19.35% 20.40% 24.36% 26.95% 20.62% 19.72% 20.40% 19.36% 16.69% 18.30% 22.79%
Net Working Capital to Revenue		 15.67% 19.29% 24.27% 22.26% -0.88% 4.05% 8.27% 11.10% 7.27% 11.51% 16.95%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $1.33 $1.33 $1.41 $1.48 $1.48 $1.35 $1.46 $1.47 $1.67 $1.52 $1.55
Adjusted Weighted Average Basic Shares Outstanding		 230.21M 230.13M 230.48M 230.69M 230.52M 231.10M 231.44M 231.34M 231.26M 230.67M 230.82M
Adjusted Diluted Earnings per Share		 $1.33 $1.32 $1.40 $1.47 $1.48 $1.34 $1.45 $1.47 $1.67 $1.52 $1.55
Adjusted Weighted Average Diluted Shares Outstanding		 231.54M 231.23M 231.26M 231.75M 231.51M 232.04M 232.30M 232.22M 232.17M 231.54M 231.47M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 230.09M 230.48M 230.71M 230.80M 231.01M 231.47M 231.54M 231.31M 230.66M 230.88M 230.95M
Normalized Net Operating Profit after Tax (NOPAT)		 323 327 343 361 366 340 362 362 409 368 374
Normalized NOPAT Margin		 19.87% 20.45% 20.81% 22.22% 21.14% 19.60% 20.89% 21.20% 23.20% 21.27% 21.04%
Pre Tax Income Margin		 23.28% 23.77% 24.08% 25.48% 24.09% 21.96% 24.04% 24.51% 25.22% 25.07% 24.87%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 17.44 19.45 22.17 23.49 18.29 11.82 14.63 17.68 21.20 23.86 27.23
NOPAT to Interest Expense		 14.03 15.88 18.30 19.62 15.17 9.65 11.85 14.42 18.58 19.40 22.19
EBIT Less CapEx to Interest Expense		 14.91 18.48 20.68 21.93 15.81 11.03 13.93 16.63 18.85 22.65 25.49
NOPAT Less CapEx to Interest Expense		 11.50 14.91 16.81 18.06 12.70 8.87 11.15 13.37 16.23 18.18 20.46
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 17.44% 17.51% 17.50% 17.48% 17.54% 18.01% 18.37% 18.90% 18.81% 18.74% 18.94%
Augmented Payout Ratio		 46.14% 32.82% 18.14% 18.10% 18.13% 18.63% 19.03% 24.10% 34.21% 34.49% 34.42%

Key Financial Trends

AMETEK Inc. (NYSE: AME) has demonstrated steady financial performance over the past four years, highlighted by consistent revenue growth, solid profitability, and a strong balance sheet. Here's a comprehensive overview of key financial trends and metrics based on the latest quarterly data and historical statements:

  • Revenue Growth: The company’s operating revenue has increased from approximately $1.56 billion in Q3 2022 to $1.78 billion in Q2 2025, reflecting steady top-line growth.
  • Profitability: Net income has shown robust growth, rising from about $297 million in Q3 2022 to $358 million in Q2 2025. Earnings per share (EPS) also improved, with diluted EPS climbing from $1.29 in Q3 2022 to $1.55 in Q2 2025.
  • Operating Efficiency: Gross profit has increased in line with revenue growth, maintaining around 35-36% gross margin, indicative of stable cost management despite rising cost of goods sold.
  • Strong Cash Flow: Operating cash flow remains strong, with $359 million generated in Q2 2025, supporting investments, dividends, and debt repayments.
  • Capital Investments: AMETEK continues to invest in property, plant, and equipment (around $29 million in Q2 2025), supporting long-term growth.
  • Dividend Policy: The company maintains a consistent dividend payout increasing slightly with a quarterly dividend of $0.31 in Q2 2025, reflecting commitment to returning capital to shareholders.
  • Debt Position: Total long-term debt increased from about $1.85 billion in Q3 2023 to around $1.53 billion in Q2 2025, showing moderate leverage with ongoing repayments. Short-term debt fluctuates, suggesting active debt management.
  • Acquisitions: Significant acquisitions were made especially in Q4 2023 ($1.99 billion) and notable amounts in other quarters. While acquisitions can drive growth, large one-time purchases increase investing cash outflows and may impact near-term liquidity.
  • Rising Current Liabilities: Current liabilities increased from $1.67 billion in Q3 2023 to about $1.87 billion in Q2 2025, potentially increasing short-term financial obligations.
  • Intangible Asset Growth: Intangible assets and goodwill together increased, reaching nearly $10 billion in Q2 2025, likely driven by acquisitions. This could pose future impairment risks if acquisitions don’t perform as expected.

Summary: AMETEK exhibits solid financial health with steady revenue and profit growth, strong operating cash flow, and prudent capital allocation toward investments and shareholder returns. The company’s active acquisition strategy has expanded its intangible asset base and debt slightly, requiring ongoing monitoring of integration success and leverage levels. Overall, AMETEK appears well-positioned with a balanced approach to growth and financial discipline.

08/28/25 10:48 PM ETAI Generated. May Contain Errors.

Financials Breakdown Chart

Frequently Asked Questions About AMETEK's Financials

When does AMETEK's fiscal year end?

According to the most recent income statement we have on file, AMETEK's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has AMETEK's net income changed over the last 10 years?

AMETEK's net income appears to be on an upward trend, with a most recent value of $1.38 billion in 2024, rising from $584.46 million in 2014. The previous period was $1.31 billion in 2023. Find out what analysts predict for AMETEK in the coming months.

What is AMETEK's operating income?
AMETEK's total operating income in 2024 was $1.78 billion, based on the following breakdown:
  • Total Gross Profit: $2.48 billion
  • Total Operating Expenses: $696.91 million
How has AMETEK's revenue changed over the last 10 years?

Over the last 10 years, AMETEK's total revenue changed from $4.02 billion in 2014 to $6.94 billion in 2024, a change of 72.6%.

How much debt does AMETEK have?

AMETEK's total liabilities were at $4.98 billion at the end of 2024, a 20.9% decrease from 2023, and a 56.4% increase since 2014.

How much cash does AMETEK have?

In the past 10 years, AMETEK's cash and equivalents has ranged from $345.39 million in 2022 to $1.21 billion in 2020, and is currently $374.00 million as of their latest financial filing in 2024.

How has AMETEK's book value per share changed over the last 10 years?

Over the last 10 years, AMETEK's book value per share changed from 13.17 in 2014 to 41.74 in 2024, a change of 216.9%.


Related Companies

This page (NYSE:AME) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners
NVIDIA's Worst Nightmare?
$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...
The Oxford Club | Sponsoredtc pixel
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...
Brownstone Research | Sponsoredtc pixel
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsoredtc pixel
What Are Some Strategies to Help Lower RMD Taxes?
Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...
SmartAsset | Sponsoredtc pixel
This is my Christian duty
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...
Paradigm Press | Sponsoredtc pixel
Trump’s national nightmare is here
AI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...
Porter & Company | Sponsoredtc pixel